These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38043045)

  • 1. Impact of Visit Volume on the Effectiveness of Electronic Tools to Improve Heart Failure Care.
    Mukhopadhyay A; Reynolds HR; King WC; Phillips LM; Nagler AR; Szerencsy A; Saxena A; Klapheke N; Katz SD; Horwitz LI; Blecker S
    JACC Heart Fail; 2024 Apr; 12(4):665-674. PubMed ID: 38043045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.
    Mukhopadhyay A; Reynolds HR; Phillips LM; Nagler AR; King WC; Szerencsy A; Saxena A; Aminian R; Klapheke N; Horwitz LI; Katz SD; Blecker S
    J Am Coll Cardiol; 2023 Apr; 81(14):1303-1316. PubMed ID: 36882134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists.
    Mukhopadhyay A; Reynolds HR; Xia Y; Phillips LM; Aminian R; Diah RA; Nagler AR; Szerencsy A; Saxena A; Horwitz LI; Katz SD; Blecker S
    Am Heart J; 2023 Apr; 258():38-48. PubMed ID: 36640860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
    J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, Design, and Patient Characteristics of a Cluster-Randomized Pragmatic Trial to Improve Mineralocorticoid Antagonist Use.
    Clark KAA; Victoria-Castro AM; Ghazi L; Yamamoto Y; Coronel-Moreno C; Kadhim BA; Riello RJ; O'Connor K; Ahmad T; Wilson FP; Desai NR
    JACC Heart Fail; 2024 Feb; 12(2):322-332. PubMed ID: 37943221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness of Eplerenone vs Spironolactone on Left Ventricular Systolic Function, Hospitalization and Cardiovascular Death in Patients With Chronic Heart Failure-HFrEF.
    Naser N; Durak-Nalbantic A; Sabanovic-Bajramovic N; Karic A
    Med Arch; 2023 Apr; 77(2):105-111. PubMed ID: 37260796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF).
    Ghazi L; Desai NR; Simonov M; Yamamoto Y; O'Connor KD; Riello RJ; Huang J; Olufade T; McDermott J; Inzucchi SE; Velazquez EJ; Wilson FP; Ahmad T
    Am Heart J; 2022 Feb; 244():107-115. PubMed ID: 34808104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.
    Desai AS; Vardeny O; Claggett B; McMurray JJ; Packer M; Swedberg K; Rouleau JL; Zile MR; Lefkowitz M; Shi V; Solomon SD
    JAMA Cardiol; 2017 Jan; 2(1):79-85. PubMed ID: 27842179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post-ST-Segment-Elevation Myocardial Infarction.
    Wong EC; Fordyce CB; Wong G; Lee T; Perry-Arnesen M; Mackay M; Singer J; Cairns JA; Turgeon RD
    J Am Heart Assoc; 2021 Jul; 10(14):e019167. PubMed ID: 34227405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid Receptor Antagonist Utilization in a Nationally Representative Heart Failure With Reduced Ejection Fraction Outpatient Population: A Cross-Sectional Study.
    Joyner KR; Soric MM; Boyle JA; Moorman JM; Fredrickson ME; Turosky JZ; Kleven CL
    Am J Ther; 2020; 27(2):e165-e176. PubMed ID: 30074530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.
    Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM
    Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.
    Berbenetz NM; Mrkobrada M
    BMC Cardiovasc Disord; 2016 Dec; 16(1):246. PubMed ID: 27905877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists: An Analysis of DAPA-HF.
    Shen L; Kristensen SL; Bengtsson O; Böhm M; de Boer RA; Docherty KF; Inzucchi SE; Katova T; Køber L; Kosiborod MN; Langkilde AM; Lindholm D; Martinez MFA; O'Meara E; Nicolau JC; Petrie MC; Ponikowski P; Sabatine MS; Schou M; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV
    JACC Heart Fail; 2021 Apr; 9(4):254-264. PubMed ID: 33549554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.
    Serenelli M; Jackson A; Dewan P; Jhund PS; Petrie MC; Rossignol P; Campo G; Pitt B; Zannad F; Ferreira JP; McMurray JJV
    JACC Heart Fail; 2020 Mar; 8(3):188-198. PubMed ID: 31926854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
    Mebazaa A; Davison B; Chioncel O; Cohen-Solal A; Diaz R; Filippatos G; Metra M; Ponikowski P; Sliwa K; Voors AA; Edwards C; Novosadova M; Takagi K; Damasceno A; Saidu H; Gayat E; Pang PS; Celutkiene J; Cotter G
    Lancet; 2022 Dec; 400(10367):1938-1952. PubMed ID: 36356631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPHASIS-HF, and TOPCAT.
    Ferreira JP; Rossello X; Eschalier R; McMurray JJV; Pocock S; Girerd N; Rossignol P; Pitt B; Zannad F
    JACC Heart Fail; 2019 Dec; 7(12):1012-1021. PubMed ID: 31779922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missed opportunities in medical therapy for patients with heart failure in an electronically-identified cohort.
    Mukhopadhyay A; Reynolds HR; Nagler AR; Phillips LM; Horwitz LI; Katz SD; Blecker S
    BMC Cardiovasc Disord; 2022 Aug; 22(1):354. PubMed ID: 35927632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.